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John A. Dodson, MD, MPH, Judith S. Hochman, MDA n extensive body of research has reportedthat women experience worse outcomescompared with men when the full spectrum
of acute coronary syndromes (ACS) are included
(1–4). Compared with men, women are more likely
to experience major bleeding (1,2) and vascular access
complications (2) post-percutaneous coronary inter-
vention, as well as a higher rate of major adverse car-
diovascular events (1) and death (4) within 1 year
post-ACS and beyond. Although the “high-risk” pro-
ﬁle of women is well established, the degree to which
this disparity is explained by differences in age and
comorbidities remains an area of debate (1,3). This
picture is complicated by the observation that the
risk associated with female sex may differ by age
strata and ACS subtype. An age–sex interaction has
been described (4) whereby younger women, but
not older women, experience worse outcomes than
their age-matched male counterparts. In addition, a
sex–ACS subtype interaction was found in a large
sample of clinical trial participants (5), whereby
women with ST-segment elevation acute coronary
syndromes (STEACS) fared worse, and women with
non–ST-segment elevation acute coronary syndromes
(NSTEACS) fared better, than men with similar clin-
ical presentations.
Changing demographics have created an im-
perative to study outcomes in older adults with
ACS, and understanding differences between older
women and older men undergoing revasculariza-
tion is one important area for exploration. To
date, comparative effectiveness studies are limited*Editorials published in JACC: Cardiovascular Interventions reﬂect the
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contents of this paper to disclose.because both women (3,6) and older adults (age
$75 years) (6) have been historically underrepre-
sented in ACS clinical trials. Among ACS subtypes in
older adults, NSTEACS is more common than STEACS
(7), and a key question among older NSTEACS pa-
tients involves whether routine early invasive man-
agement is warranted. The mean patient age was only
62 years in a meta-analysis of 7 studies that demon-
strated that routine early invasive management for
high-risk NSTEACS reduced rates of death or rein-
farction, over a mean follow-up of 17 months (8).
One particular topic of uncertainty concerning
older adults with NSTEACS centers on whether older
women beneﬁt less than older men from an early
invasive approach (9). Observational studies of older
women in clinical practice show that they are less
likely to undergo revascularization at time of
hospitalization than older men, although whether
this pattern represents appropriate case selection or
bias has been an area of debate. In a meta-analysis of
patients enrolled in the randomized FRISC II (Fast
Revascularization during InStability in Coronary ar-
tery disease), ICTUS (Invasive versus Conservative
Treatment in Unstable coronary Syndromes), and
RITA-3 (Randomized Intervention Trial of unstable
Angina) trials comparing a routine invasive strategy
with selective invasive strategy in NSTEACS, there
was a larger early hazard and less long-term beneﬁt in
women than men regardless of age (9). The degree of
beneﬁt in women may vary based on the status of
myonecrosis markers; a meta-analysis of 8 trials
comparing an invasive versus conservative approach
found that women with biomarker-positive NSTEACS
had a signiﬁcant reduction in death, myocardial
infarction (MI), or rehospitalization for ACS, whereas
the same beneﬁt was not seen in women with
biomarker negative ACS (10).
In this context, De Carlo et al. (11), in this issue of
JACC: Cardiovascular Interventions, further investi-
gated the relationship between sex, age, and out-
comes in NSTEACS by analyzing data from the Italian
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798Elderly ACS study, which pooled data from NSTEACS
patients age $75 years enrolled across 23 centers.
Patients were enrolled in a randomized controlled
trial (n ¼ 313) or a prospective cohort if they met $1
exclusion criteria (n ¼ 332) (creatinine >2.5 mg/dl,
severe lung disease, malignancy, or recent bleeding,
stroke, percutaneous coronary intervention, or coro-
nary artery bypass graft surgery). The original ran-
domized trial (12) reported that NSTEACS patients
randomized to an early aggressive strategy, compared
with an initial conservative strategy, had no signiﬁ-
cant reduction in the combined endpoint of death,
MI, stroke, and cardiovascular or bleeding read-
mission within 1 year. In the current study, the au-
thors compared characteristics between the 301
women and 344 men in the pooled randomized and
observational cohorts to analyze sex-related differ-
ences in revascularization and outcomes.SEE PAGE 791Notably, despite the age restriction, there were still
sex differences between women and men; women
were slightly older, had a higher ejection fraction,
and had lower hemoglobin. Fifty-ﬁve percent of
women underwent coronary angiography versus
61.6% of men (p ¼ 0.11) with signiﬁcantly lower rates
of revascularization for women compared with men
(37% vs. 45%, p ¼ 0.04). Although in-hospital out-
comes did not differ, at 1-year follow-up, women
experienced a signiﬁcantly higher rate of the com-
bined endpoint (death, MI, cardiac rehospitalization,
severe bleeding, stroke). Among women, those who
were revascularized had a better risk proﬁle (younger
age, higher glomerular ﬁltration rate) and a signiﬁ-
cantly lower rate of the 1-year endpoint compared
with women who were not revascularized (17.0% vs.
33.9%, p ¼ 0.002), including a lower rate of death
(8.1% vs. 21.6%, p ¼ 0.002).
The study (11) has several strengths. Older adults
with ACS are historically underrepresented in
outcome studies, and enrollment is challenging; the
authors made an admirable effort to randomize those
who were appropriate and also to follow those who
met exclusion criteria in a prospective registry. The
sample size for this age group was larger than many
reports, and follow-up data were available on all pa-
tients. The very low rate of complications in women
undergoing an invasive strategy, despite their age, is
encouraging and suggests that in the contemporary
era of revascularization, concerns over adverse
treatment effects may be exaggerated.
However, there are several factors that should be
considered in interpreting the conclusion that older
women with NSTEACS “should always be consideredfor early revascularization.” First, in older adults,
individual factors, including cognitive impairment
and patient/family goals of care, are critical compo-
nents in determining treatment. Second, the obser-
vation that women who were revascularized fared
better than women who were not revascularized was
contributed to by measured or unmeasured con-
founders in the observational cohort; for example,
the nonrevascularized group was signiﬁcantly older
and had worse renal function, which likely inﬂuenced
treatment. The practically 3-fold difference in 1-year
mortality between women who did versus did not
undergo revascularization is far outside the beneﬁt
reported with an invasive strategy in randomized
trials (10) and suggests that other variables that may
inﬂuence decision making in older patients, but are
frequently unreported (such as frailty or disability),
played a role.
Although the low reported complication rate re-
ﬂects progress in interventional procedures, the
external validity of the Italian Elderly ACS study (11) is
unclear; it was underpowered to detect infrequent
events and had a stringent deﬁnition of severe
bleeding that required rehospitalization. The rate of
severe bleeding was negligible; it occurred in no older
patients who underwent revascularization and in only
1 patient (0.5%) who did not undergo revasculariza-
tion. High rates of radial access (70%) may be partially
accountable; however, in the RIVAL (RadIal Vs
femorAL access for coronary intervention trial) study,
the rate of major bleeding with radial access for
NSTEACS (n ¼ 2,552) was 1.8%, in a population whose
mean age was 63 years (13). Site-speciﬁc attention to
management of anticoagulant or antiplatelet agents,
or other factors such as a healthier than average
population, may account for the very low observed
bleeding rate. Nonetheless, it is unclear whether
these results apply to more “typical” older adults
with ACS in practice and when systematic complete
capture of events is ensured. It is also worthy of
mention that women in the current study underwent
invasive angiography at the same rate as men but
were revascularized less, which suggests that ana-
tomic differences between the groups (e.g., higher rate
of chronic total occlusions, distal vessel disease, or
nonobstructive disease) were a factor in decision
making.
In conclusion, robust previous data demonstrate
similar risk-adjusted outcomes for men and women
with NSTEACS. The worse outcomes for this cohort of
older women compared with men, although poten-
tially a result of residual between-group differences as
potential confounders, suggest the need for further
assessment of this excess risk and understanding
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799mechanisms. The conclusion that older women with
NSTEACS undergoing revascularization can fare well
both in-hospital and after 1 year suggests that older
women should not be denied consideration of an
invasive strategy. The extremely low rate of
revascularization-related complications in the current
report (11) is encouraging and points to the need for
more robust data on the risk-beneﬁt ratio across thespectrum of older women in order to better inform
patients.
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